0.12

0.00% 0.00

Zomedica Corp (ZOM)

Overview News Price History Discussions Forecast

Zomedica Corp stock is traded at $0.12, with a volume of 1.87M. It is up +0.00% in the last 24 hours and down -13.04% over the past month. Zomedica Pharmaceuticals Corp., a development stage veterinary diagnostic and pharmaceutical company, engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. The company's lead drug product candidate is ZM-012, a tablet formulation of metronidazole targeting the treatment of acute diarrhea in dogs. It is also developing ZM-007, an oral suspension formulation of metronidazole for the treatment of acute diarrhea in small dog breeds and puppies; ZM-006, a transdermal gel formulation of methimazole targeting hyperthyroidism in cats; and ZM-011, a transdermal gel formulation of fluoxetine for the treatment of feline behavioral disorders, such as inappropriate urination. The company has a collaboration agreement with Celsee Diagnostics, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and with Seraph Biosciences, Inc. for development and commercialization of novel pathogen detection system. Zomedica Pharmaceuticals Corp. was founded in 2015 and is headquartered in Ann Arbor, Michigan.

Previous Close:

$0.12

Open:

$0.12

24h Volume:

1.87M

Relative Volume:

0.56

Market Cap:

$120.55M

Revenue:

$25.19M

Net Income/Loss:

$-34.53M

P/E Ratio:

-5.2174

EPS:

-0.023

Net Cash Flow:

$-20.62M

1W Performance:

-0.99%

1M Performance:

-13.04%

6M Performance:

-17.36%

1Y Performance:

-35.14%

1-Day Range:

$0.12

$0.1208

1-Week Range:

$0.1192

$0.1222

52-Week Range:

$0.1192

$0.2285

Zomedica Corp Stock (ZOM) Company Profile

Name

Zomedica Corp

Sector

Healthcare (1181)

Industry

Drug Manufacturers - Specialty & Generic (88)

Phone

734-369-2555

Address

100 Phoenix Drive, Suite 190, Ann Arbor, MI

Employee

Twitter

@zomedica

Next Earnings Date

2024-11-07

Latest SEC Filings

ZOM's Discussions on Twitter

Zomedica Corp Stock (ZOM) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-06-23	Initiated	Dawson James	Buy

Zomedica Corp Stock (ZOM) Latest News

Oct 31, 2024

Zomedica stock plunges to 52-week low at $0.12 amid market challenges - Investing.com India

Oct 31, 2024

Oct 24, 2024

ZOMZomedica Corp. Latest Stock News & Market Updates - StockTitan

Oct 24, 2024

Zomedica Launches Ear Cytology Quick Scan Protocol for TRUVIEW(TM) Digital Microscope & Telepathology Platform - AccessWire

Oct 24, 2024

Oct 23, 2024

Zomedica to Report Third Quarter 2024 Financial Results and Provide Business Update on November 7th at 4:30 p.m. ET - AccessWire

Oct 23, 2024

Zomedica stock plunges to 52-week low at $0.12 amid market challenges By Investing.com - Investing.com South Africa

Oct 23, 2024

Oct 15, 2024

Adversity is less terrifying than hope: Zomedica Corp (ZOM) - SETE News

Oct 15, 2024

Stock Market Recap: Zomedica Corp (ZOM) Concludes at 0.13, a -2.01 Surge/Decline - The Dwinnex

Oct 15, 2024

Zomedica Announces Sponsorship of Educational Presentations at the Fetch Coastal Conference - Lelezard

Oct 15, 2024

Oct 14, 2024

Zomedica Corp’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - The InvestChronicle

Oct 14, 2024

Oct 11, 2024